Overview
Avient Q3 sales fell 1% yr/yr, missing analyst expectations
Adjusted EPS for Q3 grew 8% yr/yr, in line with company's prior guidance
Company repaid $50 mln debt in Q3, totaling $100 mln YTD
Outlook
Avient maintains 2025 full-year adjusted EPS guidance of $2.77 to $2.87
Company updates full-year adjusted EBITDA guidance to $540 to $550 mln
Avient expects total debt repayment of $150 mln by year-end 2025
Result Drivers
MARGIN EXPANSION - Adjusted EPS growth driven by EBITDA margin expansion and lower interest and tax expenses
SECTOR GROWTH - Defense, healthcare, and telecommunications sectors showed strong sales growth
WEAK DEMAND - Weak consumer sentiment and geopolitical uncertainty negatively impacted demand in key markets
Key Details
Metric | Beat/Miss | Actual | Consensus Estimate |
Q3 Sales | Miss | $806.50 mln | $827.70 mln (6 Analysts) |
Q3 Operating Income | $67.09 mln |
Analyst Coverage
The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 7 "strong buy" or "buy", 2 "hold" and no "sell" or "strong sell"
The average consensus recommendation for the specialty chemicals peer group is "buy"
Wall Street's median 12-month price target for Avient Corp is $42.00, about 25.5% above its November 4 closing price of $31.29
The stock recently traded at 10 times the next 12-month earnings vs. a P/E of 11 three months ago
Press Release: ID:nPn4tVjkXa
For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com.
(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)
Comments